CH626093A5 - - Google Patents

Download PDF

Info

Publication number
CH626093A5
CH626093A5 CH227476A CH227476A CH626093A5 CH 626093 A5 CH626093 A5 CH 626093A5 CH 227476 A CH227476 A CH 227476A CH 227476 A CH227476 A CH 227476A CH 626093 A5 CH626093 A5 CH 626093A5
Authority
CH
Switzerland
Prior art keywords
acid
organic
glycosides
groups
mmol
Prior art date
Application number
CH227476A
Other languages
German (de)
English (en)
Inventor
Helmut Dr Vorbrueggen
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH626093A5 publication Critical patent/CH626093A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
CH227476A 1975-02-24 1976-02-24 CH626093A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752508312 DE2508312A1 (de) 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden

Publications (1)

Publication Number Publication Date
CH626093A5 true CH626093A5 (enExample) 1981-10-30

Family

ID=5939872

Family Applications (1)

Application Number Title Priority Date Filing Date
CH227476A CH626093A5 (enExample) 1975-02-24 1976-02-24

Country Status (12)

Country Link
US (1) US4082911A (enExample)
JP (1) JPS51125382A (enExample)
BE (1) BE838879A (enExample)
CA (1) CA1065315A (enExample)
CH (1) CH626093A5 (enExample)
DE (1) DE2508312A1 (enExample)
DK (1) DK138900C (enExample)
FR (1) FR2301536A1 (enExample)
GB (1) GB1542442A (enExample)
LU (1) LU74411A1 (enExample)
NL (1) NL7601625A (enExample)
SE (1) SE7602109L (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53108986A (en) * 1977-03-02 1978-09-22 Mitsui Toatsu Chem Inc Preparation of nucleosides and nucleotides
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
US4195176A (en) * 1977-10-11 1980-03-25 Warner-Lambert Company Imidazole compounds, methods for their production and conversion of said compounds into (R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
JPH029511U (enExample) * 1988-06-21 1990-01-22
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
CA2091732C (en) * 1992-07-08 1998-07-21 Anica Markovac A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
JPH07276137A (ja) * 1994-03-31 1995-10-24 Osaka Diamond Ind Co Ltd 切削・研削用工具
DE19513330A1 (de) * 1995-04-03 1996-10-10 Schering Ag Neues Verfahren zur Herstellung von Nucleosiden
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CZ301182B6 (cs) 2000-05-26 2009-12-02 Idenix (Cayman) Limited Použití nukleosidových derivátu pro výrobu farmaceutických prostredku pro lécení infekcí vyvolaných flaviviry a pestiviry
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
WO2004002422A2 (en) 2002-06-28 2004-01-08 Idenix (Cayman) Limited 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
ES2624353T3 (es) 2002-11-15 2017-07-13 Idenix Pharmaceuticals Llc 2'-Metil nucleósidos en combinación con interferón y mutación de Flaviviridae
RU2005121904A (ru) 2002-12-12 2006-01-20 Айденикс (Кайман) Лимитед (Ky) Способ получения 2`-разветвленных нуклеозидов
US6943249B2 (en) * 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US7038038B2 (en) * 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6887855B2 (en) 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
CN1812995A (zh) 2003-04-28 2006-08-02 艾登尼科斯(开曼)有限公司 工业化规模的核苷合成
MXPA06000162A (es) 2003-06-30 2006-03-21 Idenix Cayman Ltd Sintesis de ?-l-2-desoxinucleosidos.
AT502635A1 (de) * 2005-11-09 2007-05-15 Saischek Und Partner Meg Neue 1,3-dithioverbindungen, verfahren zu deren herstellung und ihre verwendung
JP5254033B2 (ja) 2005-12-23 2013-08-07 イデニク プハルマセウティカルス,インコーポレイテッド 分岐型ヌクレオシドを調製するための合成中間体の製造方法
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
US8846628B2 (en) 2008-05-15 2014-09-30 Celgene Corporation Oral formulations of cytidine analogs and methods of use thereof
WO2010014883A2 (en) 2008-08-01 2010-02-04 Dr. Reddy's Laboratories Ltd. Azacitidine process and polymorphs
EP2520581A1 (en) * 2008-08-06 2012-11-07 Sicor, Inc. Method for the determination the purity of 5-Azacytidine
AR073003A1 (es) * 2008-08-08 2010-10-06 Scinopharm Taiwan Ltd Proceso para preparar 5-azacitosina nucleosidos y sus derivados
AR076418A1 (es) * 2009-04-27 2011-06-08 Reddys Lab Inc Dr Preparacion de decitabina
KR20140019820A (ko) 2011-03-31 2014-02-17 셀진 인터내셔널 에스에이알엘 5-아자시티딘의 합성
CN108239128B (zh) * 2016-12-23 2019-03-29 江苏奥赛康药业股份有限公司 β-核苷类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354160A (en) * 1965-07-22 1967-11-21 Hoffmann La Roche Tri-lower alkyl-silyl-5-fluoropyrimidines
US3352849A (en) * 1965-10-24 1967-11-14 Merck & Co Inc 6-aza-2'-deoxyuridines
SU452961A3 (ru) * 1969-04-11 1974-12-05 Шеринг Аг. (Фирма) Способ получени пиримидиннуклеозидов
DE2122991C2 (de) * 1971-05-04 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden

Also Published As

Publication number Publication date
DK77176A (da) 1976-08-25
CA1065315A (en) 1979-10-30
DK138900B (da) 1978-11-13
FR2301536B1 (enExample) 1979-07-27
NL7601625A (nl) 1976-08-26
SE7602109L (sv) 1976-08-25
BE838879A (fr) 1976-08-24
DE2508312C2 (enExample) 1987-10-29
JPS6139318B2 (enExample) 1986-09-03
DE2508312A1 (de) 1976-09-02
US4082911A (en) 1978-04-04
JPS51125382A (en) 1976-11-01
LU74411A1 (enExample) 1976-08-13
FR2301536A1 (fr) 1976-09-17
DK138900C (da) 1979-04-30
GB1542442A (en) 1979-03-21

Similar Documents

Publication Publication Date Title
CH626093A5 (enExample)
DE2539963C2 (de) Purinverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
EP0003229B1 (de) Neues Verfahren zur Herstellung von Nucleosiden
US5329012A (en) Bis(acyloxmethyl)imidazole compounds
DE69109482T2 (de) Pyrimidinnucleosidderivat.
EP0042592A1 (de) N-Heteroaryl-alkylendiamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2235544B2 (de) 33-Disubstituierte 1-Methyl-1,2,4-triazolderivate und Verfahren zu deren Herstellung
EP0528369A2 (de) Cyclische Iminoderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE69811930T2 (de) Tricyclische triazolobenzazepinderivate, verfahren zu ihrer herstellung und antiallergische mittel
CH500203A (de) Verfahren zur Herstellung von Nucleosiden
DE3637243A1 (de) Neue phosphorsulfidderivate von deoxynucleosiden oder deoxynucleotiden und deren verwendung
EP0255894B1 (de) Pyrimidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten
DE68920648T2 (de) Verfahren zur Herstellung von O2,2'-anhydro-1-(beta-D-arabinofuranosyl)Thymin.
DD284025A5 (de) Verfahren zur herstellung von imidazo(4,5-b)pyridin-derivaten
DE3940021C2 (de) Adenosin-Derivate, deren Herstellung und Verwendung
EP0013732A2 (de) Imidazolderivate, Verfahren zu ihrer Herstellung und diese Imidazolderivate enthaltende pharmazeutische Zusammensetzungen
DE69306570T2 (de) Verfahren zur herstellung von ribonukleotid-reduktasehemmern
US4115641A (en) Ribofuranosyl-imidazole derivatives
DE2005959A1 (de) 7-Nitro-8-hydroxychinolinester, ihre Verwendung und Verfahren zur Herstellung derselben
Sasaki et al. Introduction of a 2', 3'double bond into purine ribonucleosides by selective elimination reactions
DE60313993T2 (de) Verfahren zur phosphithylierung
DE1943428C3 (de) Verfahren zur Herstellung von Pyrimidin- und 6-Azauracilnueleosiden
EP0007643B1 (de) Oxadiazolotriazinderivate
EP0385287A2 (de) Verfahren zur Herstellung von D-Mannosaminderivaten
DE2404587C2 (de) Verfahren zur Herstellung von 6-Aminopenicillansäurederivaten

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased